Frost & Sullivan applauds Borealis’ dedicated efforts to enhance its Healthcare brand and sustainable growth

Borealis recognised for its novel strategies and focus on enriching customer service and experience

Based on its recent analysis of polyolefins in the healthcare industry, Frost & Sullivan recognizes Borealis with the 2016 European Award for Growth Excellence Leadership. Borealis has set itself apart in the conservative European market by offering high-quality polyolefins through constant innovation. Its dedicated portfolio of polyethylene and polypropylene products under the Bormed™ brand as well as its outstanding technical service have enabled it to outpace the overall market in revenue growth and gain over 20% of the total European market.

In 2013, Borealis launched Bormed SB815MO under the umbrella of its polypropylene products specifically for healthcare packaging. The novel, soft product presents exceptional transparency without requiring clarifiers. For pharmaceutical packaging in particular, the use of Bormed SB815MO allows the final packaging to be sterilised at 121°C and in half the time taken by non-polypropylene materials (low-density polyethylene) with similar flexibility and stiffness.

“In the challenging healthcare market, Borealis keeps discovering new ways of customising services for its customers with a focus on value creation through innovation,” said Alfred Stern, Borealis Executive Vice President Polyolefins and Innovation. “Borealis offers global presence, serving key European markets such as Germany, France, Italy, the United Kingdom and Benelux. It also supplies healthcare customers in North America, South America, and Africa, and has been able to export to the Middle East, Asia-Pacific, and India through Borouge, our joint venture with the Abu Dhabi National Oil Company (ADNOC).”

Borealis has earned a leadership position in the market because of its Bormed products and the superiority of its customer service and engagement. Its dedicated and expert healthcare team ensures that it understands market changes and customer needs throughout the supply chain by attending conferences and trade shows and being part of associations such as the MedPharmPlast Europe.

“Borealis’ Bormed portfolio has found wide application across medical devices, pharmaceuticals, and diagnostic packaging,” said Frost & Sullivan Consulting Analyst Dr. Antonella Lisella-Wright. “The company enjoys high brand equity all over the world. Overall, it has demonstrated a keen focus on growth in the polyolefins market by fostering brand loyalty, competing effectively and carving out a unique, sustainable market position.”

Each year, Frost & Sullivan bestows this award upon the company that demonstrates excellence in growth and customer value. It recognises the superiority of the product/service as well as the overall customer, purchase, ownership, and service experience offered, which has resulted in the recipient company seeing above-market growth and greater share of wallet. The award lauds the growth, diversification, and sustainability strategies of the company.

Frost & Sullivan Best Practices awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research to identify best practices in the industry.

END

For further information please contact:

Borealis:
Virginia Mesicek
External Communications Manager
tel.: +43 (0)1 22 400 772 (Vienna, Austria)
e-mail: virginia.mesicek@borealisgroup.com
www.borealisgroup.com

Frost & Sullivan:
Chiara Carella
tel.: +44 (0)2 073438314
fax: 210 348 1003
e-mail: chiara.carella@frost.com
www.frost.com